Utilising pooled genome-wide CRISPR/Cas9 mutagenesis in ccRCC cell lines, we uncover synthetic lethal interactions for VHL, and find that Core Binding Factor β (CBF-β) loss selectively results in decreased tumour growth in ccRCCs. The gene discussed is CBFB; the disease is nonpapillary renal cell carcinoma.